Xi Peng1,2, Fan Lam1, Yudu Li1,3, Bryan Clifford1,3, Zhi-Pei Liang1,3. 1. Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. 2. Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Shenzhen, Guangdong, China. 3. Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Abstract
PURPOSE: To map brain metabolites and tissue magnetic susceptibility simultaneously using a single three-dimensional 1 H-MRSI acquisition without water suppression. METHODS: The proposed technique builds on a subspace imaging method called spectroscopic imaging by exploiting spatiospectral correlation (SPICE), which enables ultrashort echo time (TE)/short pulse repetition time (TR) acquisitions for 1 H-MRSI without water suppression. This data acquisition scheme simultaneously captures both the spectral information of brain metabolites and the phase information of the water signals that is directly related to tissue magnetic susceptibility variations. In extending this scheme for simultaneous QSM and metabolic imaging, we increase k-space coverage by using dual density sparse sampling and ramp sampling to achieve spatial resolution often required by QSM, while maintaining a reasonable signal-to-noise ratio (SNR) for the spatiospectral data used for metabolite mapping. In data processing, we obtain high-quality QSM from the unsuppressed water signals by taking advantage of the larger number of echoes acquired and any available anatomical priors; metabolite spatiospectral distributions are reconstructed using a union-of-subspaces model. RESULTS: In vivo experimental results demonstrate that the proposed method can produce susceptibility maps at a resolution higher than 1.8 × 1.8 × 2.4 mm3 along with metabolite spatiospectral distributions at a nominal spatial resolution of 2.4 × 2.4 × 2.4 mm3 from a single 7-min MRSI scan. The estimated susceptibility values are consistent with those obtained using the conventional QSM method with 3D multi-echo gradient echo acquisitions. CONCLUSION: This article reports a new capability for simultaneous susceptibility mapping and metabolic imaging of the brain from a single 1 H-MRSI scan, which has potential for a wide range of applications. Magn Reson Med 79:13-21, 2018.
PURPOSE: To map brain metabolites and tissue magnetic susceptibility simultaneously using a single three-dimensional 1 H-MRSI acquisition without water suppression. METHODS: The proposed technique builds on a subspace imaging method called spectroscopic imaging by exploiting spatiospectral correlation (SPICE), which enables ultrashort echo time (TE)/short pulse repetition time (TR) acquisitions for 1 H-MRSI without water suppression. This data acquisition scheme simultaneously captures both the spectral information of brain metabolites and the phase information of the water signals that is directly related to tissue magnetic susceptibility variations. In extending this scheme for simultaneous QSM and metabolic imaging, we increase k-space coverage by using dual density sparse sampling and ramp sampling to achieve spatial resolution often required by QSM, while maintaining a reasonable signal-to-noise ratio (SNR) for the spatiospectral data used for metabolite mapping. In data processing, we obtain high-quality QSM from the unsuppressed water signals by taking advantage of the larger number of echoes acquired and any available anatomical priors; metabolite spatiospectral distributions are reconstructed using a union-of-subspaces model. RESULTS: In vivo experimental results demonstrate that the proposed method can produce susceptibility maps at a resolution higher than 1.8 × 1.8 × 2.4 mm3 along with metabolite spatiospectral distributions at a nominal spatial resolution of 2.4 × 2.4 × 2.4 mm3 from a single 7-min MRSI scan. The estimated susceptibility values are consistent with those obtained using the conventional QSM method with 3D multi-echo gradient echo acquisitions. CONCLUSION: This article reports a new capability for simultaneous susceptibility mapping and metabolic imaging of the brain from a single 1 H-MRSI scan, which has potential for a wide range of applications. Magn Reson Med 79:13-21, 2018.
Authors: Ashley K Lotfipour; Samuel Wharton; Stefan T Schwarz; V Gontu; Andreas Schäfer; Andrew M Peters; Richard W Bowtell; Dorothee P Auer; Penny A Gowland; Nin P S Bajaj Journal: J Magn Reson Imaging Date: 2011-10-10 Impact factor: 4.813
Authors: Christian Langkammer; Kristian Bredies; Benedikt A Poser; Markus Barth; Gernot Reishofer; Audrey Peiwen Fan; Berkin Bilgic; Franz Fazekas; Caterina Mainero; Stefan Ropele Journal: Neuroimage Date: 2015-02-27 Impact factor: 6.556
Authors: James E Davison; Nigel P Davies; Martin Wilson; Yu Sun; Anupam Chakrapani; Patrick J McKiernan; John H Walter; P Gissen; Andrew C Peet Journal: Orphanet J Rare Dis Date: 2011-05-09 Impact factor: 4.123
Authors: Martin Wilson; Carole L Cummins; Lesley Macpherson; Yu Sun; Kal Natarajan; Richard G Grundy; Theodoros N Arvanitis; Risto A Kauppinen; Andrew C Peet Journal: Eur J Cancer Date: 2012-10-01 Impact factor: 9.162
Authors: Julio Acosta-Cabronero; Guy B Williams; Arturo Cardenas-Blanco; Robert J Arnold; Victoria Lupson; Peter J Nestor Journal: PLoS One Date: 2013-11-21 Impact factor: 3.240
Authors: Fuyixue Wang; Zijing Dong; Timothy G Reese; Berkin Bilgic; Mary Katherine Manhard; Jingyuan Chen; Jonathan R Polimeni; Lawrence L Wald; Kawin Setsompop Journal: Magn Reson Med Date: 2019-02-03 Impact factor: 4.668
Authors: Lihong Tang; Yibo Zhao; Yudu Li; Rong Guo; Bryan Clifford; Georges El Fakhri; Chao Ma; Zhi-Pei Liang; Jie Luo Journal: Magn Reson Med Date: 2020-07-29 Impact factor: 4.668
Authors: Jeremy W Gordon; Hsin-Yu Chen; Nicholas Dwork; Shuyu Tang; Peder E Z Larson Journal: J Magn Reson Imaging Date: 2020-02-10 Impact factor: 5.119